Amble Semaglutide Review 2026

Amble gets the commercial structure right and the price disclosure badly wrong, which is an unusual combination in a category where those two things normally fail together.

The structure: no membership fees or hidden costs, no insurance required, unlimited 24/7 support included, free shipping, and a claimed 100,000+ members treated. On terms alone that sits alongside CoreAge Rx and Fridays at the buyer-friendly end of this market.

The price: the homepage advertises plans starting at $99 per month in one panel, a GLP-1 injections card reading from $179, and a second GLP-1 card reading starting at $135 per month. Three figures, one page, no statement of which molecule or dose any of them covers.

Amble is a coordinator, not a provider

This is disclosed plainly and deserves credit for the candour, but it changes what you are buying. Amble describes itself as a managed services provider supplying technology and administrative support. It states that it connects users with licensed healthcare providers and may assist with prescription coordination through an external pharmacy network, and that it does not offer medical advice, fill prescriptions, or function as a licensed healthcare facility or pharmacy.

So the clinical relationship is with a provider reached through Amble, and the dispensing relationship is with a pharmacy Amble does not name. If something goes wrong with the preparation, the company you bought from is not the company that made it.

The longevity shelf

NAD+ injections and sermorelin injections are both listed at from $179 — the same figure as the GLP-1 card. Pricing an approved-molecule copy and an unapproved longevity peptide identically flattens a distinction that matters a great deal, and we cover why in our guides to NAD+ and peptide therapy.

What compounded semaglutide actually is

Semaglutide is the active ingredient in Ozempic and Wegovy, both FDA-approved products from Novo Nordisk. A compounded version is prepared by a pharmacy rather than manufactured by Novo Nordisk, and it is not an FDA-approved product. FDA has not evaluated it for safety, effectiveness or quality.

That distinction is the single most important thing to understand before buying. The efficacy data you have read about — the 15% average body-weight reduction, the cardiovascular outcomes — comes from trials of the branded product. Those results are routinely used to sell compounded versions that were never in the trials.

Dosing typically starts at 0.25 mg weekly and escalates over several months toward a maintenance dose, which is why dose-dependent pricing matters so much: a plan that looks cheap at the starting dose can cost several times more by the time you reach a therapeutic one.

The common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation — and are usually worst in the days after a dose increase. They are the main reason people stop. Slower titration and adequate fibre and fluid intake are the standard mitigations.

Before you buy from anyone

1. Get the total monthly cost in writing — medication plus any membership, not the headline figure.
2. Ask whether the price changes as your dose increases. This is where most of the money is lost.
3. Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
4. Confirm what happens if you stop after one month, and whether there is an auto-rebill.
5. Ask whether a refund is available if a provider declines to prescribe.
6. Tell the prescriber every medication and supplement you take, including anything bought online.